A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression ...

It is now becoming generally recognized that microarray technology will be a fundamental tool used in future genomics research. As the technology becomes more widely accessible, larger numbers of ...

With an estimated more than 10 million cases, India accounts for nearly 20% of the global epilepsy burden. The number of ...

Whole Genome Amplification (WGA) offers vast opportunities in personalized medicine, cancer research, and reproductive health ...

The Global Gene Expression Market is estimated to be valued at USD 16.56 Bn in 2025 and is expected to reach USD 23.61 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.2% from 2025 to ...

With over a decade of experience architecting and operating large-scale cloud environments across AWS, Azure, and Google ...

A large study shows that routine H&E pathology slides contain rich spatial proteomic signals that can be decoded by AI to ...

North America remains the largest contributor to the global exosomes market, driven by substantial R&D investments, expanding clinical trials, and strong collaborations between biotechnology companies ...

By comparing clinical cohorts and populations from Singapore and the US, researchers will study infectious diseases, corneal disorders, liver transplant outcomes, diabetes and lung cancer to uncover ...

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

Pregnancy loss affects nearly one in four pregnancies, with most miscarriages occurring in the first trimester and roughly half linked to genetic or chromosomal abnormalities. When these losses happen ...